Back
Akero Therapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
62
AKRO
Akero Therapeutics
Last Price:
$49.64
Seasonality Move:
22.68%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight buying pressure.
Akero Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 47.53 | Buy |
20-day SMA: | 43.67 | Buy |
50-day SMA: | 41.67 | Buy |
200-day SMA: | 35.37 | Buy |
8-day EMA: | 46.63 | Buy |
20-day EMA: | 44.43 | Buy |
50-day EMA: | 42.76 | Buy |
200-day EMA: | 36.98 | Buy |
Akero Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.8 | Buy |
Relative Strength Index (14 RSI): | 63.34 | Buy |
Chaikin Money Flow: | 338672 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (40.2 - 47.04) | Buy |
Bollinger Bands (100): | (33.25 - 50.45) | Buy |
Akero Therapeutics Technical Analysis
May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Akero Therapeutics Stock
Is Akero Therapeutics Stock a Buy?
-
Akero Therapeutics share price is 49.65 while AKRO 8-day simple moving average is 47.53, which is a Buy signal.
-
The stock price of AKRO is 49.65 while Akero Therapeutics 20-day SMA is 43.67, which makes it a Buy.
-
Akero Therapeutics 50-day simple moving average is 41.67 while AKRO share price is 49.65, making it a Buy technically.
-
AKRO stock price is 49.65 and Akero Therapeutics 200-day simple moving average is 35.37, creating a Buy signal.
AKRO Technical Analysis vs Fundamental Analysis
Buy
62
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy or a Sell?
-
Akero Therapeutics stock is rated a BuyThe current Akero Therapeutics [AKRO] share price is $49.65. The Score for AKRO is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
Akero Therapeutics Stock Info
Market Cap:
4B
Price in USD:
49.65
Share Volume:
3.2M
Akero Therapeutics 52-Week Range
52-Week High:
58.40
52-Week Low:
17.86
Buy
62
Akero Therapeutics (AKRO)
is a Buy
Akero Therapeutics Share Price Forecast
-
What is the Akero Therapeutics stock price today?The Akero Therapeutics stock price is 49.65 USD today.
-
Will AKRO stock go up or go down?Akero Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Akero Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akero Therapeutics is not overvalued.
Is Akero Therapeutics Stock a Buy?
-
Akero Therapeutics share price is 49.65 while AKRO 8-day exponential moving average is 46.63, which is a Buy signal.
-
The stock price of AKRO is 49.65 while Akero Therapeutics 20-day EMA is 44.43, which makes it a Buy.
-
Akero Therapeutics 50-day exponential moving average is 42.76 while AKRO share price is 49.65, making it a Buy technically.
-
AKRO stock price is 49.65 and Akero Therapeutics 200-day simple moving average is 36.98, creating a Buy signal.
Fundamental Analysis of Akero Therapeutics
Is Akero Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.16 per share, and a decrease next year of $0.63 per share.
Technical Analysis of Akero Therapeutics
Should I short Akero Therapeutics stock?
-
AKRO Moving Average Covergence Divergence (MACD) indicator is 1.8, suggesting Akero Therapeutics is a Buy
-
Akero Therapeutics Relative Strength Index (RSI) is 63.34, which suggest Akero Therapeutics is overbought
-
The Bollinger Bands (25) for Akero Therapeutics is (40.2 - 47.04), which suggest Akero Therapeutics is a Buy
-
The Bollinger Bands (100) for Akero Therapeutics is (33.25 - 50.45), which suggest Akero Therapeutics is a Buy
* Akero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.